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1. Introduction 
L-type Ca2+ channels play a dominant role in blood pressure regulation as suggested by the 
fall in mean arterial blood pressure in mice with selective ablation of the channel gene 
(CACN1C) in vascular smooth muscle cells (VSMCs) (Moosmang et al., 2003), the increased 
CACN1C gene expression in VSMCs in rodent models of hypertension (Pesic et al., 2004; 
Rhee et al., 2009), the anti-hypertensive effect of L-type Ca2+ channel blockers (CaBs) 
(Mancia et al., 2007) and the relationship between an autoantibody against vascular L-type 
Ca2+ channels and clinical characteristics of hypertensive patients (Zhou et al., 2008). Tran-
scripts and protein expression of CACN1C are found widely in the cardiovascular system, 
where the ion channels serve the time- and voltage-dependent influx of Ca2+ ions to initiate 
muscle contraction (Akata, 2007; Bers, 2002). It is now recognized, however, that not only 
peripheral resistance but also arterial compliance is of great importance, especially in old 
age (systolic) hypertension (Belz, 1995; Mitchell, 1999; Westerhof et al., 2009). In the large 
conduit arteries, L-type Ca2+ channels are important determinants of their mechanical prop-
erties and compliance, which are such that blood pressure and flow are propagated between 
the heart and arterioles and that thereby pulsatile flow is transformed into steady flow due 
to the “windkessel” effect (Westerhof et al., 2009). For example, CaBs increase vascular 
compliance of large elastic vessels and may be of importance for the pathogenesis and prog-
nosis of cardiovascular complications such as atherosclerosis, left ventricular hypertrophy 
and heart failure (Bellien et al., 2010; Belz, 1995; Essalihi et al., 2007; Safar et al., 1989; Slama 
et al., 1995; Vayssettes-Courchay et al., 2011). Further evidence for a role of L-type Ca2+ 
channels in atherosclerosis was obtained in carotid and femoral VSMCs, where the L-type 
Ca2+ channel gene expression differs between atherosclerotic versus non-atherosclerotic 
regions (Tiwari et al., 2006). Not only Ca2+ channels but also endothelial released nitric oxide 
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(NO) may be involved in these processes. Inhibition of endothelial NO synthase (eNOS) 
with NΩ-nitro-L-arginine methyl ester (L-NAME) or NΩ-nitro-L-arginine (L-NNA) causes 
hypertension and the decrease of basal endothelial NO release or availability may be at the 
basis of increased reactivity to vasoconstrictors in hypertension (Panza et al., 1993). Fur-
thermore, in the beginning of plaque development in animal models and in patients with 
atherosclerotic symptoms or risk factors, eNOS activity and concomitant NO release is al-
tered, especially in atherosclerosis-prone aortic segments (Fransen et al., 2008; Kauser et al., 
2000; Vanhoutte et al., 2009). Recently, we showed that L-type Ca2+ influx and its inhibition 
with CaBs may also have consequences for the capacity of NO to relax constricted mouse 
aorta. The relaxing efficacy of NO in mouse aorta was dependent on the contractile agonist, 
and more specifically, decreased when the contraction was mainly elicited via L-type Ca2+ 
influx, but increased when Ca2+ influx was partially inhibited with CaBs (Van Hove et al., 
2009). The above observations may suggest an interaction between basal NO and VSMC L-
type Ca2+ channels. An inhibitory effect of NO on Ca2+ currents in vascular smooth muscle 
and cardiomyocytes has been described (Blatter & Wier, 1994; Fischmeister et al., 2005; Tsai 
& Kass, 2009), but has not been associated with L-type Ca2+ channel-mediated contractions 
in mouse aorta. This chapter will focus on the specific role of L-type Ca2+ channels in vaso-
constriction and dilation and the interplay between NO and these L-type Ca2+ channels. 
2. Interaction between endothelial and vascular smooth muscle cells in 
intact mouse aorta 
It is generally assumed that the increase of intracellular Ca2+ in vascular endothelial cells 
results in release of NO via complex interactions with calmodulin, caveolin, endothelial 
NOS (eNOS) and tetrahydrobiopterin. NO released from the endothelial cells stimulates 
guanylate cyclase (sGC) to produce cGMP, which causes relaxation of the VSMCs via reduc-
tion of intracellular Ca2+ and the Ca2+-sensitivity of the contractile elements. Reduction of 
intracellular Ca2+ can occur via different mechanisms: inhibition of IP3-mediated Ca2+ release 
from intracellular Ca2+ stores; removal and sequestration of intracellular Ca2+ pump mecha-
nisms and/or both direct and indirect inhibition of influx of extracellular Ca2+ through volt-
age-gated Ca2+ channels (Tsai & Kass., 2009). In baseline conditions, i.e. in the absence of 
receptor-stimulation with agonists such as acetylcholine (ACh), there is basal release of NO 
through constitutive activity of endothelial eNOS in the mouse aorta. In isolated arteries, the 
basal NO production can be assessed by comparing force development by the SMCs in re-
sponse to a vasoconstrictor such as phenylephrine in the absence and presence of NOS in-
hibitors. On the other hand, receptor-stimulated eNOS activity can be determined based on 
its sensitivity for agonists like ACh to induce endothelium-dependent relaxation of pre-
constricted segments. Remarkably, basal and stimulated eNOS activity are differentially 
regulated. In rat aorta, basal NO release is more sensitive to destruction by superoxide ani-
on, and can be selectively inhibited by NΩ-monomethyl-L-arginine (L-NMMA) and asym-
metric NΩ-dimethyl-L-arginine (ADMA) without ACh responses being affected (Al-Zobaidy 
et al., 2011; Frew et al., 1993; Mian & Martin, 1995).  
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Differences between basal and stimulated eNOS activity were also observed in apolipopro-
tein E-deficient (apoE-/-) mice which develop atherosclerotic lesions in the thoracic aorta 
spontaneously at the age of 6 months, a process, which can be effectively accelerated by 
feeding these mice a high cholesterol diet. The mice exhibit preferential lesion formation in 
the aortic root and arch, and the proximal and distal part of the thoracic aorta (Crauwels et 
al., 2003; Nakashima et al., 1998; Reddick et al., 1994). This makes the apoE-/- mouse an inter-
esting model to study differences between atherosclerosis-prone and atherosclerosis-
resistant regions. We have previously shown that at the age of 4 months, hence, before de-
velopment of any visible lesions in the apoE-/- mouse model, basal and agonist-stimulated 
NO release decreased, respectively increased in atherosclerosis-prone aortic segments of 
apoE-/- in comparison with wild-type (WT) mice (Fransen et al., 2008). Because no differ-
ences in eNOS expression were found between aorta of WT and apoE-/- mice, this indicated 
that the release or efficacy of NO differed between both mouse strains. In non-stimulated 
conditions the compromised basal NO release in the apoE-/- mouse might be related to lower 
intra-endothelial Ca2+ concentrations because it could be restored to “normal” wild-type 
levels by experimentally increasing intracellular Ca2+. Agonist (ACh)-stimulated VSMC 
relaxation was temporally and dose-dependently related to the increase of endothelial Ca2+. 
Although the agonist-stimulated increase of endothelial Ca2+ was similar in both strains, 
apoE-/- segments were significantly more sensitive than WT segments in their relaxation to 
ACh. Results of these studies might suggest an important role of basal and stimulated eNOS 
activity in the pathophysiology of atherosclerotic lesions. 
In functional and molecular biological studies we have further demonstrated that before 
development of any visible lesions, not only endothelial cells but also the SMCs of the 
thoracic aorta of apoE-/- mice displayed altered intracellular Ca2+ homeostasis in comparison 
with WT VSMCs (Van Assche et al., 2007) and that within the apoE-/- strain the smooth 
muscle transcriptome is altered at atherosclerosis-prone versus atherosclerosis-resistant 
locations (Van Assche et al., 2011). Hence, not only endothelial, but also VSMC function is 
altered in atherosclerosis-prone versus -resistant segments. Whether the cross-talk between 
both cell types is affected in both directions during the process of atherosclerosis, is far less 
studied. At least, we have shown before that NO-dependent vasodilation is dependent on 
the agonist causing contraction and whenever VSMC function alters during development of 
atherosclerosis, this is also expected to affect the efficacy of endothelial cell stimulation.  
3. Relaxation of VSMCs depends on the agonist causing contraction 
Contractions of isolated arteries are often studied by initiating VSMC intracellular Ca2+ 
increase with two widely used and different stimuli. On the one hand, elevated external K+ 
depolarises the VSMCs and elicits multiphasic Ca2+ signalling and force development 
through influx of extracellular Ca2+ via L-type Ca2+ channels. On the other hand, α1-
adrenoceptor stimulation with phenylephrine also causes multiphasic Ca2+ signalling and 
force development, but the signalling is different from the depolarization-induced 
signalling. The vasodilator effects of NO differ significantly for both contractile agents. 
Bigger contractions produced by increasing concentrations of phenylephrine were all 
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equally sensitive to relaxation by ACh (figure 1) or the NO donor DEANO. In contrast, 
when the VSMCs were clamped to depolarized membrane potential (Vm) with high 
extracellular K+ concentrations, relaxation by ACh or DEANO became attenuated as K+-
induced force augmented (figure 1) (Van Hove et al., 2009). 
 
Figure 1. Relaxation induced by ACh-stimulation of mouse aortic segments at different levels of con-
traction induced by depolarization (K+) or phenylephrine (PE). A, C: absolute values; B, D: normalized 
values. Relaxation curves were fitted with sigmoidal concentration-response equations with variable 
slope, which revealed maximal responses (Emax) and the negative logarithm of the concentration result-
ing in 50% of the maximal effect (pEC50). Relaxation curves after contraction by increasing depolariza-
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tion were shifted to the right as external K+ concentration (and force level, A) increased. Not only the 
maximal amplitude produced by ACh declined significantly, but also the logEC50 of ACh was signifi-
cantly shifted to the right (E). In contrast, the normalized relaxation curves after contraction elicited by 
increasing phenylephrine concentrations were identical at each contraction level, and there was only a 
minor shift of the logEC50 (E). ***: P< 0.001 versus 20 mM K+ ###: P<0.001 versus K+; n=5; mean±SEM. 
Modified after figure 2 in (Van Hove et al., 2009) 
Simultaneous measurement of intracellular Ca2+ and force development in SMCs of de-
endothelialised aortic segments revealed important differences between Ca2+ signals in 
depolarization (50 mM K+)- or phenylephrine-constricted segments upon addition of 
DEANO, a donor of exogenous NO (figure 2). For phenylephrine-induced contractions and  
 
Figure 2. Mobilisation of intra-VSMC Ca2+ (Fura-2 technique) and concomitant isometric force before 
and after addition of 10 µM DEANO to 50 mM K+ (A) and 3 µM phenylephrine (PE) in the absence (B) 
and presence of 10 µM cyclopiazonic acid (CPA, C). D shows the mean±SEM of Ca2+ and force decrease 
after addition of DEANO. Data in D: mean±SEM, n=4 endothelium-denuded segments; *, ***: P<0.05, 
0.001 versus phenylephrine. Modified after figure 6 in (Van Hove et al., 2009). 
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VSMC Ca2+ signals, addition of NO resulted in an abrupt decrease of intracellular Ca2+, 
which could be blocked by adding cyclopiazonic acid (CPA), an inhibitor of the sarcoplas-
mic reticulum (SR) Ca2+ pump (SERCA), but not by inhibition of sGC with 1H-
[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ). Results indicated a direct stimulation by 
NO of Ca2+ re-uptake to the SR by SERCA, which is in accordance with previous reports 
(Cohen et al., 1999; Cohen & Adachi, 2006; Van Hove et al., 2009). Contractions, but not Ca2+ 
signals of VSMCs, depolarized with 50 mM K+, declined upon addition of exogenous NO. 
Nevertheless, as seen for contractions by depolarization with elevated K+, also phe-
nylephrine-induced contractions are associated with depolarization and opening of L-type 
Ca2+ channels (Akata, 2007; Plane et al., 1998; Quignard et al., 2000; Richards et al., 2001; Van 
Hove et al., 2009). If L-type Ca2+ influx is an important determinant of the vasodilator capaci-
ty of NO, why then is there an abrupt decrease of intracellular Ca2+ in the VSMCs after addi-
tion of exogenous NO to phenylephrine-elicited contractions and not to 50 mM K+-evoked 
contractions? Reduction of Ca2+ influx in depolarized segments with CaBs increased NO´s 
capacity to dilate the segments, indicating that not only the depolarized Vm of the VSMCs, 
but also the amount of Ca2+ influx determines the efficacy of NO to cause complete relaxa-
tion (Van Hove et al., 2009). Therefore, it was decided to investigate the phenylephrine- and 
K+-induced isometric contractions in more detail. 
4. Phenylephrine-induced contractions and NO 
Addition of phenylephrine causes intracellular Ca2+ release from intracellular SR Ca2+ stores 
via activation of IP3-receptors (Karaki et al., 1997). Indeed, in the absence of extracellular 
Ca2+ phenylephrine causes emptying of the SR Ca2+ stores and elicits a transient contraction 
(figure 3). This transient contraction in Ca2+-free conditions is higher with the constitutive 
activity of eNOS because inhibition of basal NO release decreased the IP3-mediated contrac-
tion by phenylephrine (figure 3). These results are compatible with previous observations 
that basal NO stimulates SERCA activity (Cohen et al., 1999; Cohen & Adachi., 2006; Van 
Hove et al., 2009). Thereby, the Ca2+ content of the SR stores of the VSMCs may be increased 
and may then lead to higher IP3-mediated contractions. The transient contractions by phe-
nylephrine in the absence of extracellular Ca2+ were dose-dependently inhibited by exoge-
nous NO (DEANO, figures 4A, B). This suggests that although basal NO might stimulate 
Ca2+ uptake to the SR via stimulation of SERCA, it inhibits the IP3-mediated release of Ca2+ 
or the concomitant transient contraction. When these experiments were repeated with addi-
tion of ACh to promote endothelial NO release, however, relaxation of phenylephrine-
induced contractions by increasing concentrations of ACh in the absence of external Ca2+ 
was completely absent (figures 4C, D). These experiments demonstrate the absolute necessi-
ty of external Ca2+ to induce ACh-stimulated release of NO from the endothelial cells. Alt-
hough ACh has been described to release Ca2+ from the SR (Fransen et al., 1998), this release 
does not stimulate eNOS to inhibit IP3-mediated contractions in mouse aortic SMCs. Hence, 
release of endogenous NO is dependent upon influx of extracellular Ca2+ into the endothelial 
cells. It has been observed before that Ca2+ influx into the endothelial cells stimulated NO 
production more potently than Ca2+ released from internal stores, which evokes little NO 
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production (Isshiki et al., 2002; Isshiki et al., 2004). This is also consistent with old observa-
tions that the resting level of cGMP falls after removal of external Ca2+ (White & Martin, 
1989). In other studies, it has been shown that the TRPV4-mediated Ca2+ signal was required 
for eNOS activation by ACh (Adapala et al., 2011; Zhang et al., 2009), also illustrating the 
necessity of Ca2+ influx for endothelial NO release. Isshiki et al. (Isshiki et al., 2004) suggest-
ed that agonist-stimulated eNOS activity in the endothelial cells was sensitive to external 
Ca2+-dependent acute changes in intracellular subcortical Ca2+ signals and that basal eNOS 
activity was maintained and regulated by subplasmalemmal Ca2+ equilibrated with extracel-
lular Ca2+. 
 
Figure 3. Effect of basal NO release on transient contractions by phenylephrine in the absence of exter-
nal Ca2+. A: IP3-mediated contractions by 2 µM phenylephrine in the absence of extracellular Ca2+ (0 mM 
Ca2+ + 2 mM EGTA) before (black, open symbol) and after inhibition (red, closed symbol) basal eNOS 
activity with 300 µM LNAME/LNNA. In B the area under the curve (AUC) shows that the transient 
contraction is significantly larger with eNOS active than with eNOS inhibited. (A: mean contraction 
(n=18) with mean force value±SEM at certain time points). 
Concomitant with the transient contraction, due to IP3-mediated Ca2+ release, α1-
adrenoceptor stimulation with phenylephrine causes also tonic contractions, which are 
measureable only in the presence of external Ca2+ (figure 5A). These contractions are medi-
ated by Ca2+ influx from the extracellular medium via Ca2+-permeable channels (SOCE or 
store-operated Ca2+-entry). The Ca2+ entry occurs via L-type Ca2+ channels, which can be 
inhibited with CaBs (figure 5B) and via non-selective cation channels, which can be inhibit-
ed with 50 µM 2-aminoethoxydiphenylborane (2-APB) (Bootman et al., 2002; Peppiatt et al., 
2003) (figure 5C). Addition of verapamil (CaB) or 2-APB between the phasic and tonic con-
traction (figure 5B, C) results in reduced SOCE and SOCE-related contraction. The SOCE 
contraction in the presence of 2-APB can be completely inhibited with CaBs, indicating it is 
mediated by L-type Ca2+ influx only, whereas the SOCE contraction in the presence of vera-
pamil can be completely inhibited with 2-APB, indicating it is mediated by non-selective 
cation Ca2+ influx only. Figure 6 compares relaxation by ACh of phenylephrine-pre-
constricted aortic segments in control conditions (contractions in the presence of external 
Ca2+), upon re-addition of external Ca2+ (SOCE contractions) and following inhibition of the 
cation channel-mediated Ca2+ influx with 2-APB. 
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Figure 4. Exogenous NO, but not ACh inhibits IP3-mediated contraction evoked by 1 µM phe-
nylephrine in the absence of external Ca2+. A: Force development by 1 µM phenylephrine (PE) after 
eNOS inhibition with 300 µM LNAME/LNNA. Force was measured 3 minutes after switching to 0 mM 
Ca2+. Before the transient contraction increasing concentrations of DEANO (indicated in nM) were 
applied. B: Dose-effect relationship for the inhibition by DEANO of the area under the curve (AUC) for 
the different IP3-mediated phenylephrine-elicited contractions. C: IP3-mediated phenylephrine-elicited 
contractions in segments with eNOS active were not influenced by increasing concentrations of ACh 
(indicated in nM). D: Dose-effect relationship for the inhibition by ACh of the AUC for the IP3-mediated 
phenylephrine-elicited contractions. LogEC50 for DEANO was -8.12±0.20 logM. Data: mean±SEM at 
certain time points; n= 4. 
Relaxation by ACh of these tonic phenylephrine-induced contractions were not different for 
control contractions (normal Krebs-Ringer solution with external Ca2+) or SOCE contractions 
(elicited by re-addition of external Ca2+ after emptying the stores with phenylephrine) 
(figure 6A). When Ca2+ influx via non-selective cation channels during the phenylephrine-
induced SOCE contraction was inhibited with 2-APB, the tonic contraction induced by 
phenylephrine was significantly smaller and relaxation by ACh was reduced by about 50% 
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(figure 6B). Results indicate that the relaxing capacity of NO is small when contractions are 
mediated by Ca2+ influx via L-type Ca2+ channels as shown before for depolarization-
mediated contractions. These results further confirmed the hypothesis that the difference in 
NO-mediated relaxation of segments depolarized with K+ versus phenylephrine, as shown 
in figure 1, is due to the amount of Ca2+ influx via L-type Ca2+ channels and the membrane 
potential (Vm) of the VSMCs. Whereas relaxation of contractions elicited with high external 
K+ was not complete, was not associated with re-uptake of Ca2+ to the SR or with a 
significant decrease of intracellular Ca2+, relaxation of phenylephrine-induced contractions 
was accompanied by inhibition of IP3-mediated contractions, by NO-mediated re-uptake of 
Ca2+ to the SR, by repolarising the VSMC Vm and by inhibition of Ca2+ influx during the tonic 
contraction (Van Hove et al., 2009). To investigate whether the effects of NO on relaxation of 
VSMCs were voltage-dependent, the effects of NO were studied at different external K+ 
concentrations or Vm of the VSMCs. 
 
Figure 5. Phasic (transient) IP3-mediated contraction by 2 µM (PE) in the absence of extracellular Ca2+, 
followed by the tonic (SOCE) contraction upon re-addition of external Ca2+ (+3.5 mM Ca2+) in control (A) 
and after addition of 10 µM verapamil (B) or 50 µM 2-APB (C) between the phasic and tonic contraction. 
Phasic force developed in B is due to non-selective cation Ca2+ influx and in C to L-type Ca2+ influx. The 
figure shows mean force traces with data±SEM at different time intervals; (n=4). 
 
Figure 6. Absolute (A) and relative (B) ACh-induced relaxation of segments constricted with 2 µM 
phenylephrine in control conditions (white) and after eliciting SOCE by previously emptying the Ca2+ 
stores and re-adding external Ca2+ (black). Relaxation curves were fitted with sigmoidal concentration-
response equations with variable slope. After inhibition of SOCE via non-selective cation channels with 
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50 µM 2-APB (blue), relaxation of phenylephrine-induced SOCE contraction by ACh, although very 
small, was completely different and compromised and could not be fitted with sigmoidal concentration-
response equations (B). Data: mean±SEM; n=7; *, ***: P<0.05, 0.001 SOCE versus control; ##, ###: P<0.01, 
0.001 2-APB versus SOCE. 
5. Depolarization-induced contractions and NO 
Aortic segments are unable to produce force upon depolarization with high K+ in 0 mM 
Ca2+. In the presence of extracellular Ca2+, depolarization-induced contractions could be 
completely inhibited with CaBs, but were not affected by blocking the ryanodine receptor 
(15 µM ryanodine) or IP3 receptor of the SR (50 µM 2-APB) (Peppiatt et al., 2003). These 
observations suggested that K+-induced contractions of mouse aortic segments are solely 
supported by influx of Ca2+ via L-type Ca2+ channels. Figure 1 showed that ACh-induced 
relaxations of contractions produced by 20 mM extracellular K+ (mild depolarization) were 
near complete and occurred with a sensitivity close to the ACh-sensitivity for relaxations of 
phenylephrine-induced contractions. However, for stronger depolarization, relaxation was 
severely compromised. The latter results suggest that relaxation of depolarization-induced 
contractions depended upon Vm of the VSMCs. Vm of the endothelial cells did not 
significantly contribute to the sensitivity to ACh because ACh-induced relaxations of 
phenylephrine-induced contractions at high extracellular K+ in the presence of CaB were not 
attenuated (Van Hove et al., 2009). Why are relaxations of depolarized segments dependent 
on Vm of the VSMCs, i.e. complete for phenylephrine-induced contractions, which are also 
accompanied by depolarization of the segments, nearly complete for mild K+-induced 
depolarization and severely attenuated for high K+-induced depolarization? To solve this 
question we investigated the depolarization-induced contraction in more detail.  
5.1. Depolarization-induced window contractions 
Electrophysiological studies in isolated SMCs revealed the occurrence of a voltage range 
(window), in which L-type Ca2+ channels do not inactivate, leading to a “time-independent” 
influx of Ca2+ ions (Curtis & Scholfield, 2001; Fleischmann et al., 1994; Ganitkevich & 
Isenberg, 1990; Matsuda et al., 1990; Smirnov & Aaronson, 1992). This window influx of Ca2+ 
ions has been shown to lead to an increase of intracellular Ca2+ within the SMCs 
(Fleischmann et al., 1994), but has never been associated with the tonus of blood vessels. By 
clamping Vm of the endothelial and SMCs in aortic segments to depolarized potentials by 
elevating extracellular K+, we were able to show a window contraction within the voltage 
range of overlap of activation and inactivation curves of the L-type Ca2+ channels 
(manuscript submitted, see also figure 8). In order to correlate the extracellular K+ with Vm of 
the VSMCs of the aortic segments, Vm was measured with sharp glass intracellular 
microelectrodes (filled with 2 M KCl, tip resistances between 65 and 90 MΩ, HEKA EPC9 
amplifier in the zero current-clamp mode). Deviation of measured Vm from the K+ 
equilibrium potential (Nernstian VK) was largest at physiological K+ concentrations, 
indicating that in non-stimulated VSMCs other ions than K+ contribute in setting the resting 
Vm (figure 7A). However, by adding levcromakalim, a drug that sets Vm to VK by activating 
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ATP-dependent K+ channels (Knot & Nelson, 1998; Weston et al., 2002), Vm of the VSMCs 
could be hyperpolarised to VK. Indeed, when measured with intracellular microelectrodes, 
the resting Vm of VSMCs of aortic segments was -60.1±2.6 mV (n=8), which could be 
repolarized with levcromakalim to -84 mV. 
 
Figure 7. A: Relationship between extracellular K+ and measured Vm (red asterisks) of mouse aortic 
VSMCs. Levcromakalim (green asterisk) caused hyperpolarization of Vm to VK. The Nernstian relation-
ship between VK and extracellular K+ is indicated by the black symbols and dotted line. B: Relationship 
between estimated and measured membrane potential (Vm) of mouse aortic VSMCs. Linear regression 
of the relationship between estimated and measured Vm (open circles, straight line) reveals slope of 0.90 
(95% confidence interval 0.69-1.12), which was not significantly different from unity (dotted line) (R2= 
0.84). Full circle represents Vm in the presence of 200 nM levcromakalim at 5.9 mM K+. 
Taking into account the shift of the contraction curves at different K+ in the presence of 
levcromakalim (see figure 8), Vm of the VSMCs evoked by increasing extracellular K+ (Vclamp) 
could be estimated. Vclamp changed with K+ concentration according to Vclamp = 61*log(([K+]o + 
6)/[K+]i)) with [K+]o the extracellular K+ concentration in mM, which is elevated by 6 mM as 
revealed by the shift induced by levcromakalim (figure 8), and [K+]i the intracellular K+ con-
centration (assumed to be 140 mM). Figure 7B shows that the relationship between the esti-
mated and measured Vm was close to unity. This means that in the following graphs the K+ 
axis could be replaced by a Vclamp axis. This is shown in figure 8, where the effects of 
levcromakalim on K+-induced isometric contractions at different K+ concentrations are con-
sidered. By adding levcromakalim, the aortic segments were all set to the same Vm, i.e. VK.  
Depolarization by elevated K+ causes the isometric contraction to increase until maximal 
force of 100% was attained at 50 mM K+. At higher K+, force decreased again, leading to a 
bell-shape of the force-K+ relationship, which agrees well with the bell-shaped voltage 
dependency of the L-type Ca2+ currents measured with voltage-clamp in single, isolated 
SMCs. The “steady-state” contractions observed at each K+ concentration are window 
contractions, which are due to influx of Ca2+ via non-inactivating L-type Ca2+ channels. 
Differentiation of these contractions (%force/mM K+ change) reveals a K+-dependent 
contraction curve, which fits very well with the intracellular Ca2+ mobilized during the 
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depolarizing voltage clamp steps in single SMCs (Fleischmann et al., 1994). It is clear that 
levcromakalim, which causes repolarization of Vm from -60 to -80 mV, shifts the window 
contraction to higher extracellular K+, indicating that in the presence of levcromakalim 
higher extracellular K+ is needed to attain the same isometric contraction as in control. When 
contractions at different external K+ concentrations were plotted as a function of Vclamp, 
contraction curves in the absence and presence of levcromakalim were identical (figure 8C, 
D). Hence, levcromakalim shifted the K+-dependence of the isometric contraction, but not 
the voltage-dependence, suggesting that levcromakalim does not affect L-type Ca2+ channel 
gating properties. Results further suggest that at resting Vm of the VSMCs (-50 to -60 mV), 
Vclamp situates within the window voltage range, which results in continuous baseline Ca2+ 
influx and concomitant tonus via open L-type Ca2+ channels.  
 
Figure 8. A and B: Effects of 1 µM levcromakalim on the K+-dependence of the isometric contraction. 
Extracellular K+ was increased from 2 mM to 124 mM in control (+300 µM LNAME/LNNA to inhibit 
eNOS) and in the presence of 1 µM levcromakalim to hyperpolarize the VSMCs to VK. The fitted (sig-
moidal concentration-response curves with variable slope) curves in A were differentiated in B to show 
K+-dependence of the change of force development per mM change of K+. Levcromakalim caused a 
significant rightward shift (± 6 mM) of the curves in A and B. C and D: Effects of 1 µM levcromakalim 
on the voltage-dependence of the isometric contraction. Vclamp was estimated as indicated in the text for 
control, i.e. absence of levcromakalim, and in the presence of levcromakalim, where Vclamp equals VK. 
There was no shift of the voltage-dependence of the L-type Ca2+ channel-mediated contraction and the 
differentiated curves in D were equal. Data: mean±SEM; n=6; *, **, ***: P<0.05, 0.01, 0.001 levcromakalim 
versus control. 
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5.2. Depolarization-induced window contractions and NO 
To investigate the effects of basal NO release on voltage-dependent L-type Ca2+ channel-
mediated contractions, the contraction evoked by the increase of extracellular K+ was 
measured before and after inhibition of eNOS with 300 µM LNAME/LNNA. NO has been 
described to activate voltage-gated K+ channels, to hyperpolarize VSMCs and to decrease 
the intracellular Ca2+ concentration (Edwards et al., 2010; Quignard et al., 2000; Yuan et al., 
1996). To compensate for the hyperpolarizing effects of NO or depolarizing effects of eNOS 
inhibition, 1 µM levcromakalim was added to set Vm of all the segments to VK (figure 9). 
Inhibition of basal NO release shifted the contraction window to hyperpolarized potentials. 
A possible explanation is that S-nitrosylation of cysteine residues of the channel changes the 
voltage-dependence of the L-type Ca2+ channel-mediated contraction. Effects of NO and 
cGMP on L-type Ca2+ current have been described before. They might occur via an indirect 
mechanism through a NO-cGMP-PKG pathway and/or a direct mechanism mediated by S-
nitrosylation (Almanza et al., 2007). The α1C-subunit of the L-type Ca2+ channel contains 
more than 10 cysteine residues that modulate channel gating and is constitutively S-
nitrosylated in the mouse heart (Sun et al., 2006; Tamargo et al., 2010). According to this 
hypothesis, basal NO release should diminish Ca2+ influx via the L-type Ca2+ window at 
physiological Vm, leading to vasodilation. It will be interesting to test this hypothesis with 
intracellular VSMC Ca2+ measurements. Is intracellular Ca2+ decreasing upon addition of NO 
to segments pre-contracted with different K+ (different Vclamp)? Indirect evidence for the 
hypothesis is provided by the experiments of figure 1, where it was shown that the relaxing 
capacity of NO increased when external K+ was decreased. 
 
Figure 9. The contribution of basal NO release to window contractions. Vclamp-force curves for segments 
with active eNOS (blue, control segments) and segments with eNOS inhibited (red, 300 µM 
LNAME/LNNA combination) were constructed in the presence of 1 µM levcromakalim, which allowed 
to express force data as a function of Vclamp (= VK). The fitted (sigmoidal concentration-response curves 
with variable slope) curves in A were differentiated in B to show the voltage-dependence of the change 
of force development per mV change of Vclamp. eNOS-inhibition caused a significant leftward shift of the 
eNOS active curves in A and B. Data: mean±SEM; n=6; **, ***: P<0.01, 0.001 eNOS inactive versus eNOS 
active. 
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Figure 10. Effects of exogenous NO on contraction window in mouse aortic segments following re-
polarization of Vm to VK with 1 µM levcromakalim. eNOS was active (blue circles) or inhibited (red 
circles) and in this situation exogenous NO could be applied (100 nM DEANO, purple circles). The 
fitted (sigmoidal concentration-response curves with variable slope) curves in A were differentiated in 
B to show the voltage-dependence of the change of force development per mV change of Vclamp. Data: 
mean±SEM; n=4; *, **, ***: P<0.05, 0.01, 0.001 eNOS inactive versus eNOS active; #, ##, ###: P<0.05, 0.01, 
0.001 +100 nM DEANO versus eNOS inactive. 
The shift of the contraction window by eNOS inhibition could be completely reversed by 
adding exogenous NO (100 nM DEANO) (figure 10). The addition of exogenous NO to 
segments, in which eNOS activity was inhibited, caused a rightward (depolarising) shift of 
the voltage-dependency of contraction. Also in this situation, effects of eNOS inhibition or 
exogenous NO addition on Vm were avoided by performing the experiments in the presence 
of 1 µM levcromakalim. Results confirmed that NO altered the voltage-dependency of the L-
type Ca2+ channel-mediated contraction, probably by direct effects of NO on the channel´s 
gating properties. It should be noted that for strong depolarization above -20 mV (90 and 
124 mM K+), addition of exogenous NO caused significant relaxation of the pre-constricted 
segments. Hence, the window contraction in the presence of NO is narrower than in the 
absence of NO (figure 10B). Whether these results can also be explained by NO-dependent 
changes of the voltage dependence of activation of the L-type Ca2+ channels needs further 
investigation. 
The above data may provide an explanation for the absence of a decrease of intracellular 
VSMC Ca2+ with relaxation upon addition of NO to segments depolarized with 50 mM K+, 
whereas similar experiments in phenylephrine-constricted segments displayed relaxation 
with an abrupt decrease of intracellular Ca2+ upon addition of NO (see figure 2). Firstly, 
depolarization with elevated K+ did not empty the SR Ca2+ stores, and, hence, did not 
stimulate SOCE via NO-sensitive non-selective cation channels. Secondly, at 50 mM K+ Vm of 
the VSMCs was clamped at depolarized potentials and NO cannot elicit hyperpolarisation 
of Vm. Thirdly, at 50 mM K+, the window Ca2+ influx and concomitant contraction were 
maximal and addition of NO will only cause small relaxations, probably via effects on Ca2+-
sensitivity and not on intracellular Ca2+ concentrations. 
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6. NO efficacy and VSMC L-type Ca2+ channels along the thoracic aorta 
Increased stiffness of elastic arteries represents an early risk factor for cardiovascular 
diseases (O'Rourke & Mancia, 1999) and, therefore, the assessment of mechanical properties 
of the aorta is important to understand the mechanisms of cardiovascular disease. It has 
been shown that in the aorta of C57Bl6 mice, the circumferential modulus is greatest (most 
rigid) near the diaphragm, and that about 85% of volume compliance is in the thoracic 
compared with abdominal aorta (Guo & Kassab, 2003). Because as well NO as CaBs have 
been described to de-stiffen large arteries (Fitch et al., 2006; Safar et al., 1989; Safar et al., 
2011), we wondered whether NO release (basal and stimulated) and L-type Ca2+ channel 
activity differed along the length of the thoracic aorta. 
 
Figure 11. Dissection of the mouse thoracic aorta in five 2 mm wide segments. The mouse aorta was 
removed from the animal, stripped of adherent tissue and dissected systematically. Starting at the 
diaphragm, the ascending thoracic aorta was cut in segments of 2 mm width (TA5 up to TA1). 
In this part of the chapter, we show some preliminary data on aortic segment differences 
with respect to NO and L-type Ca2+ channels. In order to test whether the release or efficacy 
of NO differs between different locations along the thoracic aorta of C57Bl6 mice, the aorta 
was divided into 5 segments (figure 11) and in each segment endogenous and exogenous 
NO efficacy was determined. Basal release of NO and its efficacy to counteract contraction 
was measured in each aortic segment by measuring isometric contractions to the α1-
adrenoceptor agonist phenylephrine before and after inhibition of eNOS with 300 µM 
LNAME/LNNA. The increase of force (Δ force) and the shift of logEC50 (Δ logEC50) by 
eNOS inhibition are an index of the basal release of endogenous NO in each segment 
(figures 12A and B).  
Although not significant, the effects of eNOS inhibition on phenylephrine-induced contrac-
tions were smaller in the atherosclerosis-resistant segments TA2, TA3 and TA4 as compared 
with the atherosclerosis-prone segments TA1 and TA5 (figure 12A). In accordance, inhibi-
tion of eNOS caused a significantly larger shift of the segment´s sensitivity to phenylephrine 
in the atherosclerosis-prone segment TA1 compared with the other segments (figure 12B). 
Results may point to a higher basal eNOS activity or release of basal NO in the atherosclero-
sis-prone segments TA1 and TA5. Subsequently, endogenous release of NO was evoked by 
adding increasing concentrations of ACh to segments pre-contracted with 1 µM phe-
nylephrine. Figures 12C and D show maximal relaxation evoked by and sensitivity (logEC50) 
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for ACh in each segment. Although TA1 seemed to have the highest NO efficacy without 
endothelial stimulation (basal NO, figures A and B), this atherosclerosis-prone segment 
caused only relaxations of about 65% and displayed the lowest sensitivity for ACh-induced 
relaxations. This was due to endothelial dysfunction because the effects of exogenous NO 
(DEANO) were not significantly different between the different aortic segments (figures 12 
E and F). Results of these experiments show that endothelial function (basal and stimulated 
release of NO) may differ between atherosclerosis-prone and –resistant segments along the 
thoracic aorta of wild-type mice, which may have important consequences for the tonus and 
compliance of the thoracic aorta.  
 
Figure 12. Basal and agonist-stimulated NO efficacy for different aortic segments. A and B show maxi-
mal increase of force development (Δforce) and the shift of the logEC50 (ΔlogEC50) for phenylephrine 
after inhibition of eNOS with the 300 µM LNAME/LNNA combination (measure of basal NO release). C 
and D show % relaxation and logEC50 for ACh-induced relaxation of the contraction elicited with 1 µM 
phenylephrine (stimulated endogenous NO), hence in the absence of LNAME/LNNA. E and F show % 
relaxation and logEC50 for DEANO-induced relaxation of the contraction elicited with 1 µM phe-
nylephrine (exogenous NO) after inhibition of eNOS with 300 µM LNAME/LNNA. Data: mean ±SEM; 
n=6 or more; *, **, ***: P<0.05, 0.01, 0.001 versus TA1. 
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When the impact of ACh-stimulated eNOS activity on L-type Ca2+ channels was investigated 
further (see figure 6), but now in atherosclerosis-prone and -resistant segments, figures 13 A 
and C show that as well in the presence of external Ca2+ as after eliciting contraction by re-
addition of Ca2+ to zero Ca2+ (SOCE contraction), relaxation in prone segments in comparison 
with resistant segments was attenuated. When SOCE via cation-selective channels was 
inhibited with 50 µM 2-APB, the SOCE contraction by phenylephrine was smaller in the 
resistant than in the prone segments (figure 13B, values at -9 logM ACh). Because this SOCE-
contraction by phenylephrine is due to influx of Ca2+ via L-type Ca2+ channels only (see figure 
5), this suggests that the L-type Ca2+ channel-mediated SOCE contraction in prone segments is 
larger than in resistant segments. This L-type Ca2+ channel-mediated contraction by 
phenylephrine in prone segments displayed attenuated relaxation to ACh (figure 13D), again 
pointing to the lower capacity of NO to relax contractions evoked by L-type Ca2+ influx. 
 
Figure 13. Absolute (mN, A, B) and relative (%, C, D) ACh-induced relaxation of atherosclerosis-prone 
(TA1,white symbols) and atherosclerosis-resistant (TA2/TA3, black symbols) segments constricted with 
2 µM phenylephrine in the presence of extracellular Ca2+ (control conditions, circles) and after eliciting 
contraction by re-addition of external Ca2+ to zero Ca2+ (SOCE, squares). Relaxation curves were fitted 
with sigmoidal concentration-response equations with variable slope and significantly differed between 
prone and resistant segments. After inhibition of SOCE via non-selective cation channels with 50 µM 2-
APB (triangles), the SOCE contraction, which is mediated through L-type Ca2+ influx only, was larger in 
prone than in resistant segments. Relaxation of these phenylephrine-induced SOCE contractions by 
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ACh were compromised more in prone than in resistant segments and could not be fitted with sig-
moidal concentration-response equations (B). Data: mean±SEM; n=7; *, **, ***: P<0.05, 0.01, 0.001 prone 
versus resistant; #, ###: 2-APB versus SOCE. 
7. Conclusions 
The present chapter investigated the relaxing efficacy of NO for contractions induced by α1-
adrenoceptor stimulation with phenylephrine or by depolarization with elevated extracellu-
lar K+ and confirmed previous observations that relaxation by NO is attenuated when the 
contraction was due to L-type Ca2+ influx (Van Hove et al., 2009). Contractions, which were 
initiated by Ca2+ release from the SR as with phenylephrine were very sensitive to endoge-
nous or exogenous NO. Here, NO caused relaxation by inhibiting the IP3-mediated contrac-
tion, by stimulating Ca2+ re-uptake to the SR via stimulation of SERCA, by inhibiting SOCE 
via cation channels and by reducing SOCE via L-type Ca2+ channels. Although phe-
nylephrine has been described to cause depolarization of the VSMCs, Vm is not clamped at 
depolarized values and addition of NO is expected to cause hyperpolarization, thereby 
reducing Ca2+ influx via L-type Ca2+ channels. By clamping Vm to depolarized values with 
elevation of K+, we were able to show contractions due to Ca2+ influx via L-type Ca2+ chan-
nels only and more specifically, to Ca2+ influx via non-inactivating Ca2+ channels (window 
contraction). This window contraction could be decreased by repolarizing Vm of VSMCs 
with levcromakalim (an opener of ATP-dependent K+ channels) or by adding exogenous NO 
as long as the extracellular K+ concentration was below 50 mM. Because NO also shifted the 
voltage-dependence of the window contraction in the presence of levcromakalim, it was 
hypothesized that NO, but not levcromakalim exerted a direct effect on the gating proper-
ties of the L-type Ca2+ channel. Although it has been described that NO affects L-type Ca2+ 
channels directly via S-nitrosylation (Almanza et al., 2007), an effect on the voltage-
dependent contraction has not been directly demonstrated yet. Hence, it is hypothesized 
that in mouse aortic segments NO changed the voltage-dependence of the contraction medi-
ated by L-type Ca2+ influx, probably via S-nitrosylation of the cysteine residues located in 
the gating part of the channel´s α1C-subunit.  
An interplay between NO and L-type Ca2+ channels was also suggested by a number of 
other observations: a) When treated with the CaB, lacidipine, Western-type diet-evoked 
hypertension and atherosclerosis development in apoE-deficient mice was reduced, whereas 
endothelial function was preserved (Kyselovic et al., 2005), b) after partly inhibiting L-type 
Ca2+ influx induced by high K+ with the CaB nifedipine, relaxation by exogenous NO was 
ameliorated (Van Hove et al., 2009) and c) ApoE-/- mice, which spontaneously develop ath-
erosclerotic lesions at the age of 6 months when fed a normal diet, displayed altered Ca2+ 
homeostasis at the age of 4 months, hence, before development of plaques. In comparison 
with wild-type C57Bl6 mice, they showed higher baseline intracellular Ca2+ in the SMCs 
(Van Assche et al., 2007), lower baseline Ca2+ in endothelial cells and decreased basal but 
normal or even enhanced agonist-evoked NO release and efficacy (Fransen et al., 2008). 
The present study might also provide an explanation for the unique features of the antihyper-
tensive classes of CaBs with different chemical structure (phenylalkylamines such as verapamil, 
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benzothiazepines such as diltiazem and dihydropyridines such as nifedipine). They reduce 
blood pressure more effectively in hypertensive than in normotensive subjects (Leonetti et al., 
1982) and they inhibit L-type Ca2+ influx more effectively in vascular tissue than in heart 
(Godfraind et al., 1984; Godfraind, 2005; Striessnig et al., 1998). Several attempts have been 
made to explain these unique features. In hypertension, there is an increase of reactivity to vas-
oconstrictors, which is not only due to a higher number of L-type Ca2+ channels (Godfraind, 
2005; Pesic et al., 2004; Pratt et al., 2002), but also to depolarization of the resting potential of 
hypertensive VSMCs (Morel & Godfraind, 1994; Pesic et al., 2004). Depolarization leads to an 
increased proportion L-type Ca2+ channels in the inactivated state, which according to the 
“modulated receptor theory” may have higher affinity to CaBs than channels in the resting state 
(Bean et al., 1986; Godfraind, 2005; Morel & Godfraind, 1987). Cardiac muscle cells are hyperpo-
larized with respect to VSMC and hence less susceptible to block by CaBs. Another specific 
feature of L-type Ca2+ channels is that their population is not homogeneous because of the oc-
currence of alternatively spliced isoforms (Koch et al., 1990). Among the 55 known human L-
type Ca2+ channel exons 19 undergo alternative splicing and display differences in tissue distri-
bution, physiology, pharmacology and disease-related up- and/or down-regulation (Liao et al., 
2005; Tang et al., 2007; Tiwari et al., 2006). Some of these isoforms were dominant in aorta (> 
50%) and less abundant in heart (<5%). Moreover, the VSM-specific splice variant of the L-type 
Ca2+ channel displayed hyperpolarised window current at voltages where there is overlap be-
tween activation and inactivation curves and enhanced inhibition by nifedipine in comparison 
with the predominant cardiac isoform (Liao et al., 2007). The selective affinity of CaBs for the 
different L-type Ca2+ channel subpopulations may further contribute to the different susceptibil-
ity of VSMC or cardiac cells to CaBs. Because the L-type Ca2+ channel window in VSMCs may 
be responsible for “time-independent” baseline Ca2+ influx at normal resting or slightly depolar-
ized membrane potentials (Fleischmann et al., 1994; Poburko et al., 2004), depolarization of the 
resting potential by hypertension not only favours the inactivated state of the L-type Ca2+ chan-
nel, but is also expected to increase L-type Ca2+ influx via the L-type Ca2+ channel window and 
to evoke inhibition by CaBs (Fleischmann et al., 1994). 
Preliminary results of this chapter, finally, indicate that NO efficacy and L-type Ca2+ channel 
distribution may differ along the length of the thoracic aorta. Basal and stimulated eNOS 
activation or NO release occurred differently along the thoracic aorta. Close to the aortic 
arch, segments released more basal NO but less stimulated NO than segments close to the 
diaphragm. Similarly, L-type Ca2+ channel distribution and related window contraction 
were higher in atherosclerosis-prone than in -resistant segments. These preliminary data 
need to be further explored, but may have important consequences for the compliance of the 
different aortic segments and their susceptibility to the development of atherosclerosis.  
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